Stock Analysis on Net

Merck & Co. Inc. (NYSE:MRK)

$24.99

Statement of Comprehensive Income

Paying users area


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Merck & Co. Inc., consolidated statement of comprehensive income

US$ in millions

Microsoft Excel
12 months ended: Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income
Net unrealized gain (loss) on derivatives, net of reclassifications
Net unrealized gain (loss) on investments, net of reclassifications
Benefit plan net gain (loss) and prior service credit (cost), net of amortization
Cumulative translation adjustment
Other comprehensive income (loss) net of taxes
Comprehensive income (loss)
Comprehensive (income) loss attributable to noncontrolling interests
Comprehensive income (loss) attributable to Merck & Co., Inc.

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).

Comprehensive income item Description The company
Net income attributable to Merck & Co., Inc. The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Merck & Co. Inc. net income attributable to Merck & Co., Inc. increased from 2021 to 2022 but then decreased significantly from 2022 to 2023.
Comprehensive income (loss) attributable to Merck & Co., Inc. Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners. Merck & Co. Inc. comprehensive income (loss) attributable to Merck & Co., Inc. decreased from 2021 to 2022 and from 2022 to 2023.